Vitae Pharmaceuticals, Inc — Contributions, Lobbying & Contracts | Poliscope

Vitae Pharmaceuticals, Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$82.9M

240 transactions

Summary

Vitae Pharmaceuticals, Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $24.6MSales: $23.7M37 insiders

Date	Insider	Type	Value
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$2.4M
2016-10-25	Fratamico Arthur(Chief Business Officer)	D	$2.4M
2016-10-25	Applebaum Scott(General Counsel)	D	$1.8M
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$342K
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$336K
2016-10-25	HAYDEN DONALD J JR	D	$286K
2016-10-25	Fratamico Arthur(Chief Business Officer)	D	$239K
2016-10-25	SANTINI GINO	D	$221K
2016-10-25	HAYDEN DONALD J JR	D	$221K
2016-10-25	Bernstein Karen	D	$200K
2016-10-25	JUNIUS DANIEL M	D	$193K
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$191K
2016-10-25	Fratamico Arthur(Chief Business Officer)	D	$177K
2016-10-25	Fratamico Arthur(Chief Business Officer)	D	$175K
2016-10-25	SANTINI GINO	D	$114K
2016-10-25	Bernstein Karen	D	$114K
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$99K
2016-10-25	Fratamico Arthur(Chief Business Officer)	D	$91K
2016-10-25	SANTINI GINO	D	$86K
2016-10-25	Morris Richard Steven(Chief Financial Officer)	D	$17K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR